Calliditas reports strong Q4 growth, eyes future expansion By Investing.com
© Reuters. STOCKHOLM - Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX), a biopharmaceutical firm specializing in uncommon ailments, introduced vital ...
© Reuters. STOCKHOLM - Calliditas Therapeutics AB (NASDAQ: CALT) (STO: CALTX), a biopharmaceutical firm specializing in uncommon ailments, introduced vital ...
Copyright © 2023 expertrefi.org.
expertrefi.org is not responsible for the content of external sites.
Copyright © 2023 expertrefi.org.
expertrefi.org is not responsible for the content of external sites.